Fate Therapeutics, Inc. (FATE) — Analyst estimates
Consensus analyst estimates for Fate Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 1.38M | -0.28 | 4 |
| 2027 | 987.38K | -0.27 | 2 |
| 2028 | 636.61K | -0.38 | 3 |
| 2029 | 22.67M | -0.36 | 4 |
| 2030 | 156.31M | -0.67 | 1 |
Consensus analyst estimates by fiscal year.